|
Name |
Botryochromone
|
Molecular Formula | C18H18O5 | |
IUPAC Name* |
6-[2-(furan-2-yl)propyl]-5-hydroxy-7-methoxy-2-methylchromen-4-one
|
|
SMILES |
CC1=CC(=O)C2=C(C(=C(C=C2O1)OC)CC(C)C3=CC=CO3)O
|
|
InChI |
InChI=1S/C18H18O5/c1-10(14-5-4-6-22-14)7-12-15(21-3)9-16-17(18(12)20)13(19)8-11(2)23-16/h4-6,8-10,20H,7H2,1-3H3
|
|
InChIKey |
DUIOOHYZYJNWOT-UHFFFAOYSA-N
|
|
Synonyms |
Botryochromone; CHEMBL4441827
|
|
CAS | NA | |
PubChem CID | 139591695 | |
ChEMBL ID | CHEMBL4441827 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 314.3 | ALogp: | 3.7 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 68.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 23 | QED Weighted: | 0.77 |
Caco-2 Permeability: | -4.763 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.021 | Pgp-substrate: | 0.235 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.856 |
Blood-Brain-Barrier Penetration (BBB): | 0.019 | Plasma Protein Binding (PPB): | 94.51% |
Volume Distribution (VD): | 0.454 | Fu: | 6.21% |
CYP1A2-inhibitor: | 0.902 | CYP1A2-substrate: | 0.96 |
CYP2C19-inhibitor: | 0.928 | CYP2C19-substrate: | 0.556 |
CYP2C9-inhibitor: | 0.902 | CYP2C9-substrate: | 0.927 |
CYP2D6-inhibitor: | 0.334 | CYP2D6-substrate: | 0.89 |
CYP3A4-inhibitor: | 0.47 | CYP3A4-substrate: | 0.706 |
Clearance (CL): | 6.25 | Half-life (T1/2): | 0.533 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.307 |
Drug-inuced Liver Injury (DILI): | 0.502 | AMES Toxicity: | 0.101 |
Rat Oral Acute Toxicity: | 0.538 | Maximum Recommended Daily Dose: | 0.322 |
Skin Sensitization: | 0.515 | Carcinogencity: | 0.514 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.439 |
Respiratory Toxicity: | 0.74 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004732 | 0.594 | D0G4KG | 0.393 | ||||
ENC002207 | 0.594 | D06GCK | 0.385 | ||||
ENC001417 | 0.592 | D04AIT | 0.284 | ||||
ENC001495 | 0.551 | D08SKH | 0.279 | ||||
ENC000962 | 0.488 | D0FA2O | 0.276 | ||||
ENC002186 | 0.472 | D07MGA | 0.276 | ||||
ENC006031 | 0.446 | D0K8KX | 0.265 | ||||
ENC001518 | 0.425 | D0QD1G | 0.265 | ||||
ENC005716 | 0.419 | D0Z3DY | 0.263 | ||||
ENC005717 | 0.419 | D0O6KE | 0.262 |